Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel

Michael Millward, P. Mainwaring, A Mita, K. Federico, G.K. Lloyd, N. Reddinger, S. Nawrocki, M. Mita, M.A. Spear

Research output: Contribution to journal › Article › peer-review

Access to Document

@article{86fa6d8f84e64dd884604c925501a5d7,

title = "Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel",

author = "Michael Millward and P. Mainwaring and A Mita and K. Federico and G.K. Lloyd and N. Reddinger and S. Nawrocki and M. Mita and M.A. Spear",

year = "2012",

doi = "10.1007/s10637-011-9642-4",

language = "English",

volume = "30",

pages = "1065--1073",

journal = "Investigational New Drugs",

issn = "0167-6997",

publisher = "Kluwer Academic Publishers",

}

TY - JOUR

T1 - Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel

AU - Millward, Michael

AU - Mainwaring, P.

AU - Mita, A

AU - Federico, K.

AU - Lloyd, G.K.

AU - Reddinger, N.

AU - Nawrocki, S.

AU - Mita, M.

AU - Spear, M.A.

PY - 2012

Y1 - 2012

U2 - 10.1007/s10637-011-9642-4

DO - 10.1007/s10637-011-9642-4

M3 - Article

C2 - 21327495

SN - 0167-6997

VL - 30

SP - 1065

EP - 1073

JO - Investigational New Drugs

JF - Investigational New Drugs

ER -